Generics

Sulfamethoxazole and trimethoprim oral suspension has a market value of approximately $19 million.

The Everstone Group is investing up to $50 million in Series B funding to expand and accelerate Slayback's pipeline of complex generic and specialty pharmaceutical products.

Aurobindo began selling clorazepate dipotassium tablets in three dosage strengths on Jan. 1.

Amitiza had a market value of approximately $427 million for the 12 months ended Sept. 30, 2020, according to IQVIA.

Biocon's tacrolimus capsules reduces the body’s ability to reject a transplanted organ.

The Mahwah, N.J.-based company has received approval or tentative approval for generics of Otezla, Cialis and Horizant.

Amphastar's generic is a synthetic peptide product that the FDA has deemed to be bioequivalent and thus therapeutically equivalent to Eli Lilly’s Glucagon Emergency Kit for Low Blood Sugar. 

Aminocaproic acid has a market value of approximately $12.7 million, according to IQVIA.